- Home
- TRVG vs ETON Comparison
TRVG vs ETON Comparison
Compare TRVG & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVG
- ETON
- Stock Information
- Founded
- TRVG 2005
- ETON 2017
- Country
- TRVG Germany
- ETON United States
- Employees
- TRVG N/A
- ETON N/A
- Industry
- TRVG EDP Services
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- TRVG Technology
- ETON Health Care
- Exchange
- TRVG Nasdaq
- ETON Nasdaq
- Market Cap
- TRVG 306.5M
- ETON 329.8M
- IPO Year
- TRVG N/A
- ETON 2018
- Fundamental
- Price
- TRVG $4.29
- ETON $14.68
- Analyst Decision
- TRVG Hold
- ETON Strong Buy
- Analyst Count
- TRVG 5
- ETON 3
- Target Price
- TRVG $2.94
- ETON $24.00
- AVG Volume (30 Days)
- TRVG 106.0K
- ETON 270.3K
- Earning Date
- TRVG 04-29-2025
- ETON 03-18-2025
- Dividend Yield
- TRVG N/A
- ETON N/A
- EPS Growth
- TRVG N/A
- ETON N/A
- EPS
- TRVG N/A
- ETON N/A
- Revenue
- TRVG $477,118,749.00
- ETON $39,011,000.00
- Revenue This Year
- TRVG $9.85
- ETON $22.19
- Revenue Next Year
- TRVG $6.77
- ETON $109.55
- P/E Ratio
- TRVG N/A
- ETON N/A
- Revenue Growth
- TRVG N/A
- ETON 23.29
- 52 Week Low
- TRVG $1.60
- ETON $3.03
- 52 Week High
- TRVG $5.03
- ETON $18.41
- Technical
- Relative Strength Index (RSI)
- TRVG 59.97
- ETON 47.04
- Support Level
- TRVG $3.90
- ETON $14.28
- Resistance Level
- TRVG $4.37
- ETON $15.73
- Average True Range (ATR)
- TRVG 0.32
- ETON 1.02
- MACD
- TRVG -0.04
- ETON 0.03
- Stochastic Oscillator
- TRVG 62.28
- ETON 55.23
About TRVG trivago N.V.
trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. It derives a majority of revenue from the Developed Europe segment. The Developed Europe segment is comprised of Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, and others.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.